These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38916435)

  • 1. Lentivirus-modified hematopoietic stem cell gene therapy for advanced symptomatic juvenile metachromatic leukodystrophy: A long-term follow-up pilot study.
    Zhang Z; Jiang H; Huang L; Liu S; Zhou X; Cai Y; Li M; Gao F; Liang X; Tsang KS; Chen G; Ma CY; Chai YH; Liu H; Yang C; Yang M; Zhang X; Han S; Du X; Chen L; Hwu WL; Zhuo J; Lian Q
    Protein Cell; 2024 Jun; ():. PubMed ID: 38916435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access.
    Fumagalli F; Calbi V; Natali Sora MG; Sessa M; Baldoli C; Rancoita PMV; Ciotti F; Sarzana M; Fraschini M; Zambon AA; Acquati S; Redaelli D; Attanasio V; Miglietta S; De Mattia F; Barzaghi F; Ferrua F; Migliavacca M; Tucci F; Gallo V; Del Carro U; Canale S; Spiga I; Lorioli L; Recupero S; Fratini ES; Morena F; Silvani P; Calvi MR; Facchini M; Locatelli S; Corti A; Zancan S; Antonioli G; Farinelli G; Gabaldo M; Garcia-Segovia J; Schwab LC; Downey GF; Filippi M; Cicalese MP; Martino S; Di Serio C; Ciceri F; Bernardo ME; Naldini L; Biffi A; Aiuti A
    Lancet; 2022 Jan; 399(10322):372-383. PubMed ID: 35065785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial.
    Sessa M; Lorioli L; Fumagalli F; Acquati S; Redaelli D; Baldoli C; Canale S; Lopez ID; Morena F; Calabria A; Fiori R; Silvani P; Rancoita PM; Gabaldo M; Benedicenti F; Antonioli G; Assanelli A; Cicalese MP; Del Carro U; Sora MG; Martino S; Quattrini A; Montini E; Di Serio C; Ciceri F; Roncarolo MG; Aiuti A; Naldini L; Biffi A
    Lancet; 2016 Jul; 388(10043):476-87. PubMed ID: 27289174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding caregiver descriptions of initial signs and symptoms to improve diagnosis of metachromatic leukodystrophy.
    Eichler F; Sevin C; Barth M; Pang F; Howie K; Walz M; Wilds A; Calcagni C; Chanson C; Campbell L
    Orphanet J Rare Dis; 2022 Oct; 17(1):370. PubMed ID: 36195888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving newborn screening test performance for metachromatic leukodystrophy: Recommendation from a pre-pilot study that identified a late-infantile case for treatment.
    Wu THY; Brown HA; Church HJ; Kershaw CJ; Hutton R; Egerton C; Cooper J; Tylee K; Cohen RN; Gokhale D; Ram D; Morton G; Henderson M; Bigger BW; Jones SA
    Mol Genet Metab; 2024 May; 142(1):108349. PubMed ID: 38458124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting clinical phenotypes of metachromatic leukodystrophy based on the arylsulfatase A activity and the ARSA genotype? - Chances and challenges.
    Santhanakumaran V; Groeschel S; Harzer K; Kehrer C; Elgün S; Beck-Wödl S; Hengel H; Schöls L; Haack TB; Krägeloh-Mann I; Laugwitz L
    Mol Genet Metab; 2022 Nov; 137(3):273-282. PubMed ID: 36240581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Juvenile Metachromatic Leukodystrophy Compared With Nontransplanted Control Patients.
    Groeschel S; Kühl JS; Bley AE; Kehrer C; Weschke B; Döring M; Böhringer J; Schrum J; Santer R; Kohlschütter A; Krägeloh-Mann I; Müller I
    JAMA Neurol; 2016 Sep; 73(9):1133-40. PubMed ID: 27400410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive demyelinating polyneuropathy after hematopoietic cell transplantation in metachromatic leukodystrophy: a case series.
    Beerepoot S; Boelens JJ; Lindemans C; de Witte MA; Nierkens S; Vrancken AFJE; van der Knaap MS; Bugiani M; Wolf NI
    J Neurol; 2024 Jul; 271(7):4028-4038. PubMed ID: 38564053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic Stem Cell Transplantation with Mesenchymal Stromal Cells in Children with Metachromatic Leukodystrophy.
    Cabanillas Stanchi KM; Böhringer J; Strölin M; Groeschel S; Lenglinger K; Treuner C; Kehrer C; Laugwitz L; Bevot A; Kaiser N; Schumm M; Lang P; Handgretinger R; Krägeloh-Mann I; Müller I; Döring M
    Stem Cells Dev; 2022 Apr; 31(7-8):163-175. PubMed ID: 35323019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the natural history of metachromatic leukodystrophy from interviews with caregivers.
    Harrington M; Whalley D; Twiss J; Rushton R; Martin S; Huynh L; Yang H
    Orphanet J Rare Dis; 2019 Apr; 14(1):89. PubMed ID: 31036045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report.
    Boucher AA; Miller W; Shanley R; Ziegler R; Lund T; Raymond G; Orchard PJ
    Orphanet J Rare Dis; 2015 Aug; 10():94. PubMed ID: 26245762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: A compound heterozygous mutations in
    Wang BL; Lu FL; Sun YC; Wang HJ
    Front Neurol; 2022; 13():1011019. PubMed ID: 36324388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypic characterization of Brazilian patients with infantile and juvenile forms of metachromatic leukodystrophy.
    Virgens MY; Siebert M; Bock H; Burin M; Giugliani R; Saraiva-Pereira ML
    Gene; 2015 Aug; 568(1):69-75. PubMed ID: 25965562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atidarsagene autotemcel for metachromatic leukodystrophy.
    Messina M; Gissen P
    Drugs Today (Barc); 2023 Feb; 59(2):63-70. PubMed ID: 36811406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodevelopmental outcomes of umbilical cord blood transplantation in metachromatic leukodystrophy.
    Martin HR; Poe MD; Provenzale JM; Kurtzberg J; Mendizabal A; Escolar ML
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):616-24. PubMed ID: 23348427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular screening of the major mutations in the ARSA gene in patients with metachromatic leukodystrophy].
    Horovenko NH; Ol'khovych NV; Pichkur NO
    Tsitol Genet; 2002; 36(5):43-8. PubMed ID: 12442547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognizing early MRI signs (or their absence) is crucial in diagnosing metachromatic leukodystrophy.
    Schoenmakers DH; Beerepoot S; Krägeloh-Mann I; Elgün S; Bender B; van der Knaap MS; Wolf NI; Groeschel S
    Ann Clin Transl Neurol; 2022 Dec; 9(12):1999-2009. PubMed ID: 36334091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biochemical study of 29 Brazilian patients with metachromatic leukodystrophy.
    Artigalás O; Lagranha VL; Saraiva-Pereira ML; Burin MG; Lourenço CM; van der Linden H; Santos ML; Rosemberg S; Steiner CE; Kok F; de Souza CF; Jardim LB; Giugliani R; Schwartz IV
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S257-62. PubMed ID: 20596894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy.
    Doerr J; Böckenhoff A; Ewald B; Ladewig J; Eckhardt M; Gieselmann V; Matzner U; Brüstle O; Koch P
    Mol Ther; 2015 Sep; 23(9):1519-31. PubMed ID: 26061647
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.